|
Volumn 23, Issue 8, 2012, Pages 677-679
|
Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors
|
Author keywords
B6 12 vitamins; cardiovascular risk; folates; homocysteine
|
Indexed keywords
ACETYLCYSTEINE;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
COLESTIPOL;
CYANOCOBALAMIN;
FIBRIC ACID DERIVATIVE;
HOMOCYSTEINE;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
METFORMIN;
NICOTINIC ACID;
OMEGA 3 FATTY ACID;
PYRIDOXINE;
S ADENOSYLMETHIONINE;
TAURINE;
TICLOPIDINE;
AMINO ACID BLOOD LEVEL;
ANTICOAGULANT THERAPY;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CORONARY ARTERY DISEASE;
DRUG EFFICACY;
DRUG INTERMITTENT THERAPY;
DRUG MECHANISM;
HUMAN;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
REVIEW;
RISK REDUCTION;
ACETYLCYSTEINE;
ASPIRIN;
BLOOD VESSELS;
CARDIOVASCULAR DISEASES;
DIURETICS;
FATTY ACIDS, OMEGA-3;
FOLIC ACID;
HOMOCYSTEINE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
PLATELET AGGREGATION INHIBITORS;
S-ADENOSYLMETHIONINE;
TICLOPIDINE;
VITAMIN B 12;
VITAMIN B 6;
|
EID: 84870203944
PISSN: 09575235
EISSN: 14735733
Source Type: Journal
DOI: 10.1097/MBC.0b013e3283597586 Document Type: Review |
Times cited : (6)
|
References (6)
|